ReviewAdvances in experimental medicine and biology2026
Protein-Mediated Virulence in Mycobacterium tuberculosis.
Review in Advances in experimental medicine and biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The pathogenic potential of Mycobacterium tuberculosis (Mtb), the etiological agent of tuberculosis, is attributable primarily to its complex and highly specialized repertoire of molecular determinants, comprising both proteins and lipids. These virulence factors operate synergistically to facilitate evasion of host immune defenses, establish persistent infection, and sustain prolonged survival within the host environment, often for months or even years. These factors can be systematically classified according to their functional roles, molecular composition, and spatial localization within or in proximity to the bacterial cell, collectively underscoring Mtb's extraordinary capacity to adapt to, manipulate, and thrive within hostile host environments. Central to Mtb's defense and survival strategy is its robust lipid and fatty acid metabolism, which orchestrates the biosynthesis of a complex, lipid-rich, waxy cell wall. This structure serves as a formidable physical and biochemical barrier against immune-mediated clearance and antimicrobial agents. Enzymes such as KasA and AccD6 are indispensable in the biosynthetic pathway of mycolic acids, long-chain fatty acids that confer the cell envelope with structural rigidity, impermeability, and resistance to chemical and enzymatic attack. Complementing this, proteins such as Rv2952 contribute to the synthesis of phenolic glycolipids (PGLs), which effectively "cloak" the bacterial surface by masking antigenic epitopes, thereby facilitating immune evasion. Among the most prominent lipid virulence factors is trehalose dimycolate (TDM), commonly referred to as the "cord factor." TDM plays a critical role in granuloma formation. These dense aggregates of immune cells characterize tuberculosis pathology and modulate host cell death pathways in a manner that promotes bacterial persistence and dissemination. Supporting this protective lipid barrier are lipoproteins such as LprG and LpqH, which modulate host immune signaling pathways to attenuate inflammatory responses, thereby enhancing bacterial survival. Concurrently, proteins such as Rv2700 contribute to maintaining cell wall stability, particularly under environmental and immunological stress. Collectively, these factors significantly impede adequate immune clearance, enabling Mtb to persist despite sustained host immune pressure. A particularly potent virulence mechanism employed by Mtb involves specialized secretion systems, notably the ESX-1 Type VII secretion system (T7SS). This molecular apparatus functions analogously to a syringe, translocating effector proteins directly into host cells. Key secreted proteins such as ESAT-6 and CFP-10 disrupt host cell membrane integrity and modulate immune responses, while accessory Esp proteins facilitate their secretion and delivery. The PE/PPE protein families further enhance immune evasion by promoting antigenic variation, thereby enabling Mtb to circumvent adaptive immune recognition. A defining feature of Mtb's survival strategy is its sophisticated regulation of host cell death pathways. The bacterium inhibits apoptosis, the programmed cell death pathway, via proteins such as NuoG, which interfere with mitochondrial stress signaling cascades. Conversely, Mtb can selectively induce apoptosis through ESAT-6 when such cell death is advantageous for bacterial dissemination. Moreover, Mtb actively induces necrosis, a pro-inflammatory and lytic form of cell death, through toxins such as tuberculosis necrotizing toxin (TNT) and lipid virulence factors including phthiocerol dimycocerosates (PDIMs). These effectors compromise host cell membrane integrity and deplete critical metabolites such as NAD
Indexed as
Identifiers
41207939What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.